Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical significance of immunohistochemically detectable p53 protein in renal cell carcinoma.

European urology - 1 Jan 1997

Shiina H, Igawa M, Urakami S, Shirakawa H, Ishibe T, Kawanishi M

Abstract excerpt

OBJECTIVE: To elucidate the clinical significance of p53 protein in renal cell carcinoma (RCC). MATERIALS AND METHODS: The p53 protein in the paraffin-embedded materials taken from 72 patients with RCCs was evaluated immunohistochemically and was compared with the histological findings, expression of proliferating cell nuclear antigen (PCNA), genetic instability as assessed by 2c deviation index (2cDI) and 5c...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Prognosis
Share to Genes, p53
Share to Kidney

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Kidney Neoplasms

Share to Multivariate Analysis

Share to Mutation

Share to Predictive Value of Tests

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 9032539
DOI: 10.1159/000474422

Genes

PCNA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance of immunohistochemically detectable p53 protein in renal cell carcinoma.PMID 9032539Read ↗

P53 mutations and other prognostic factors of renal cell carcinoma.Semantic proximity Read ↗

p53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets?Semantic proximity Read ↗

p53 and HER-2 alterations in renal cell carcinoma.Semantic proximity Read ↗

Association of immunohistochemical staining for p53 with metastatic progression and poor survival in patients with renal cell carcinoma.Semantic proximity Read ↗

Sensitivity and specificity of p53 protein detection by immunohistochemistry in patients with urothelial bladder carcinoma.Semantic proximity Read ↗

[Clinical importance of p53 gene mutation and PCNA expression in ureteral and renal pelvic cancers].Semantic proximity Read ↗

p53 is Functionally Inhibited in Clear Cell Renal Cell Carcinoma (Ccrcc): A Mechanistic and Correlative Investigation into Genetic and Molecular Characteristics.Semantic proximity Read ↗

p53 is functionally inhibited in clear cell renal cell carcinoma (ccRCC): a mechanistic and correlative investigation into genetic and molecular characteristics.Semantic proximity Read ↗

Elevated content of p53 protein in the absence of p53 gene mutations as a possible prognostic marker for human renal cell tumors.Semantic proximity Read ↗

Selected immunohistochemical features of conventional renal cell carcinomas coexpressing P53 and MDM2.Semantic proximity Read ↗

Study of mutated p53 protein by immunohistochemistry in urothelial neoplasm of urinary bladder.Semantic proximity Read ↗

Relationship between p53 gene mutation and protein expression: clinical significance in transitional cell carcinoma of the bladder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.